CCR5 and gastric cancer: Because CCL5/CCR5 is one the central axis of activation for DNA repair from damage caused by CDDP [15] and DNA repair is one of the most important mechanisms of CDDP resistance [41–43], we hypothesized that CCR5 inhibition by MVC could enhance the action of CDDP in gastric cancer platinum-resistant cells [35].